Hot Alert: Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), Cummins Inc. (NYSE:CMI), Mattson Technology Inc. (NASDAQ:MTSN), Macquarie Infrastructure Company LLC (NYSE:MIC)

Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) belongs to Healthcare sector. Its net profit margin is -61.40% and weekly performance is 10.68%. On last trading day company shares ended up $8.08. Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) distance from 50-day simple moving average (SMA50) is 29.08%. On July 7, Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) announced details of its planned Phase 3 clinical trial for 1404, a developmental stage small molecule designed to help visualize prostate cancer by targeting prostate specific membrane antigen (PSMA). Following recent End-of-Phase 2 interactions with the U.S. Food and Drug Administration (FDA), the design and key elements of a Phase 3 clinical trial for 1404 have been finalized.

On 14 July, Cummins Inc. (NYSE:CMI) shares fell -0.25% and was closed at $129.87. CMI EPS growth in last 5 year was 33.10%. Cummins Inc. (NYSE:CMI) year to date (YTD) performance is -8.91%. The Board of Directors of Cummins Inc. (NYSE:CMI) approved an increase in the Company’s quarterly cash dividend on common stock of 25 percent to 97.5 cents per share from 78 cents per share. The dividend is payable on September 1, 2015, to shareholders of record on August 21, 2015.

Mattson Technology Inc. (NASDAQ:MTSN) ended the last trading day at $3.40. Company weekly volatility is calculated as 4.48% and price to cash ratio as 9.64. Mattson Technology Inc. (NASDAQ:MTSN) showed a weekly performance of 1.49%. Mattson Technology, Inc. (NASDAQ:MTSN), a leading supplier of advanced wafer fabrication equipment used by semiconductor manufacturers, stated its Millios, millisecond anneal (MSA) systems have been shipped to multiple customers’ advanced foundry / logic production sites over the past six consecutive quarters. This consistency in system shipments is the result of the market acceptance of the Millios as a primary production system for technology nodes at 20 nanometer and below.

Macquarie Infrastructure Company LLC (NYSE:MIC) shares advanced 0.87% in last trading session and ended the day at $83.87. MIC Gross Margin is 49.20% and its return on assets is 17.20%. Macquarie Infrastructure Company LLC (NYSE:MIC) quarterly performance is 2.77%. Macquarie Infrastructure Corporation (NYSE:MIC) announced that a performance fee of $135.6 million is payable to its external Manager, Macquarie Infrastructure Management (USA) Inc., as a result of outperformance by the Company of its benchmark index over the second quarter of 2015. The fee represents outperformance of MIC’s benchmark of approximately 10.8% during the quarter ended June 30, 2015.

Leave a Reply

Your email address will not be published. Required fields are marked *